SyncAV PMT
SyncAV Post-Market Trial
In 1,288 CRT recipients with left bundle branch block, dynamic AV-delay optimisation did not reduce the reduction in LV end-systolic volume at 12 months compared with a fixed AV delay.
An algorithm that keeps fusion pacing as the PR interval wanders produced the narrower paced QRS it was designed for and no better remodelling at a year — the electrical target moved, the ventricle did not. The primary endpoint at P = 0.054 will be quoted as a near miss; it is a miss, and the responder analysis agrees. What may survive is the subgroup with a PR interval of 185 ms or longer, where fixed programming loses fusion and the clinical composite halved — half the cohort, entirely exploratory, and the trial's own hypothesis for the next one.